Auckland, New Zealand

Lai Ming Ching

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations of Lai Ming Ching in Pharmaceutical Research

Introduction

Lai Ming Ching is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that inhibit tryptophan dioxygenases. His work has the potential to impact therapeutic approaches for various medical conditions, including cancer.

Latest Patents

Lai Ming Ching holds two patents that focus on inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their therapeutic applications. The patents describe pharmaceutical compositions comprising 3-aminoisoxazolopyridine compounds with IDO1 and/or TDO inhibitory activity. These compounds are characterized by specific structural formulas, where W, X, Y, and Z can be CR, N, or N-oxide, with at least one being N or N-oxide. The patents also outline methods for using these compounds in the treatment of various conditions, such as cancer.

Career Highlights

Lai Ming Ching is associated with Auckland Uniservices Limited, where he continues to advance his research in pharmaceutical innovations. His work is recognized for its potential to lead to new therapeutic strategies in treating serious health conditions.

Collaborations

Lai Ming Ching collaborates with several professionals in his field, including Brian Desmond Palmer and Swarnalatha Akuratiya Gamage. Their combined expertise contributes to the advancement of research and development in pharmaceutical sciences.

Conclusion

Lai Ming Ching's innovative work in the field of pharmaceuticals highlights the importance of research in developing new therapies. His patents reflect a commitment to addressing critical health challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…